AdaptHealth Corp. (AHCO) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2025
Loading P/E history...
AHCO Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, AdaptHealth Corp. (AHCO) trades at a price-to-earnings ratio of -22.6x, with a stock price of $11.73 and trailing twelve-month earnings per share of $-0.59.
The current P/E is 116% below its 5-year average of 143.0x. Over the past five years, AHCO's P/E has ranged from a low of 15.9x to a high of 1060.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, AHCO trades at a 201% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, AHCO trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AHCO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AHCO P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 27.5 | - | +53% | |
| $3B | 16.3 | - | +3% | |
| $5B | 8.3 | - | +264% | |
| $26B | 24.9 | - | +224% | |
| $161B | 57.6 | 2.65 | +23% | |
| $100B | 21.6 | - | +31% | |
| $30B | 21.8 | 1.25 | +37% | |
| $2B | 6.9Lowest | 0.67Best | +817%Best | |
| $17B | 30.5 | - | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AHCO Historical P/E Data (2018–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $8.95 | $0.55 | 16.3x | -89% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $9.43 | $0.54 | 17.5x | -88% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $10.84 | $0.57 | 19.0x | -87% |
| FY2024 Q4 | $9.52 | $0.60 | 15.9x | -89% | |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $12.17 | $0.12 | 101.4x | -29% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $12.43 | $0.12 | 103.6x | -28% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $19.22 | $0.26 | 73.9x | -48% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $18.78 | $0.43 | 43.7x | -69% |
| FY2022 Q2 | $18.04 | $0.52 | 34.7x | -76% | |
| FY2022 Q1 | $16.03 | $0.55 | 29.1x | -80% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $24.46 | $0.39 | 62.7x | -56% |
| FY2019 Q3 | Mon Sep 30 2019 00:00:00 GM | $10.18 | $0.01 | 1060.4x | +641% |
Average P/E for displayed period: 143.0x
See AHCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHCO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAHCO — Frequently Asked Questions
Quick answers to the most common questions about buying AHCO stock.
Is AHCO stock overvalued or undervalued?
AHCO trades at -22.6x P/E, below its 5-year average of 143.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AHCO's valuation compare to peers?
AdaptHealth Corp. P/E of -22.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is AHCO's PEG ratio?
AHCO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2025.